Status: current, Defined. Date: 30-Apr 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4808891000168117 | glycomacropeptide formula with docosahexaenoic acid and low phenylalanine oral liquid, 15 x 237 mL bottles (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4808901000168118 | glycomacropeptide formula with docosahexaenoic acid and low phenylalanine oral liquid, 15 x 237 mL bottles | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| glycomacropeptide formula with docosahexaenoic acid and low phenylalanine oral liquid, 15 x 237 mL bottles | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| glycomacropeptide formula with docosahexaenoic acid and low phenylalanine oral liquid, 15 x 237 mL bottles | has MPUU | glycomacropeptide formula with docosahexaenoic acid and low phenylalanine oral liquid, 237 mL bottle | true | Inferred relationship | Some | 124174370 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| PKU Sphere20 oral liquid, 15 x 237 mL bottles | Is a | True | glycomacropeptide formula with docosahexaenoic acid and low phenylalanine oral liquid, 15 x 237 mL bottles | Inferred relationship | Some |
Reference Sets
List of Excluded Medicinal Items reference set
Description inactivation indicator reference set
Medicinal product pack reference set
FHIR